Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

US Fund KPS explored takeover offer for UK's Elementis –sources

Published 24/01/2024, 18:59
Updated 25/01/2024, 17:16
© Reuters.

(This Jan. 24 story has been corrected to change the name of the stakeholder to Franklin Mutual Advisers, from Franklin Mutual Advisors, in paragraph 8)

By Amy-Jo Crowley and Emma-Victoria Farr

LONDON (Reuters) - KPS Capital Partners recently explored a bid for UK specialty chemicals maker Elementis (LON:ELM) but has since paused its work, two people familiar with the matter told Reuters.

The New York-based private equity firm in December submitted an offer valuing the FTSE 250 company at about 160p per share, but the Elementis board wanted around 180p, one of the people said.

Spokespeople for Elementis and KPS declined to comment.

Shares in Elementis, which makes a range of chemical and personal care products, rose by as much as 10.5% in early trading in London on Thursday.

By 0847 GMT, they were up 8.1% at 134 pence, making them the biggest percentage gainer on the FTSE 350 index. Elementis closed at 125 pence on Wednesday, giving it a market value of 735 million pounds.

Elementis has already rebuffed other takeover bids, in 2020 from US-based Mineral Technologies and in 2021 from Nasdaq-listed Innospec.

It follows disappointment from shareholders in Elementis in recent months over the firm’s performance.

New Jersey-based Franklin Mutual Advisers, which has an about 9.2% stake in Elementis, in September urged the board to find a buyer for the company.

It criticised the company’s "stagnant" share price and recent "value destructive acquisitions", which it said had undermined confidence in management's ability to drive growth.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Odyssean Capital, which has an about 3.1% stake, and Schroders (LON:SDR) Investment Management, which owns about 3.8%, backed the request to put the company up for sale, The Times reported.

Elementis rebuffed the calls saying that an immediate sale of the chemicals group was not ideal given the "substantial value still to be realised."

In its latest trading update, Elementis said it expects adjusted operating profit to be between $102-104 million for 2023, up from $100.5 million a year earlier. It added it remains focused on achieving an operating margin of above 19% by 2026 and its target of below 1.5 times net debt and core profit.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.